Evidence map›Paper›PMID 34131117›Full record

ArticleNature communications2021

Genome sequencing unveils a regulatory landscape of platelet reactivity.

Ali R Keramati, Ming-Huei Chen, Benjamin A T Rodriguez, Lisa R Yanek, Arunoday Bhan, Brady J Gaynor, Kathleen Ryan, Jennifer A Brody, Xue Zhong, Qiang Wei and 19 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Leveraging Mendelian randomization to inform drug discovery and development for ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets.Research and practice in thrombosis and haemostasis · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. An Update on the Genetics of IgA Nephropathy.Journal of clinical medicine · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. [Research progress of Molecular diagnostic technique in Venous Thromboembolism].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 5 countries.

Ali R Keramati *Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-8728-1508
Ming-Huei Chen *Division of Intramural Research, Population Sciences Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
Benjamin A T Rodriguez *Division of Intramural Research, Population Sciences Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
Lisa R YanekGeneSTAR Research Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-7117-1075
Arunoday BhanBoston Children's Hospital, Boston, MA, USA.
Brady J GaynorDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-4142-0613
Kathleen RyanDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Jennifer A BrodyCardiovascular Health Research Unit, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0001-8509-148X
Xue ZhongVanderbilt Genetics Institute, Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Qiang WeiVanderbilt Genetics Institute, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
NHLBI Trans-Omics for Precision (TOPMed) Consortium
Kai KammersBiostatistics and Bioinformatics, Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kanika KanchanDivision of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kruthika IyerDivision of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Madeline H KowalskiDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
Achilleas N PitsillidesThe Framingham Heart Study, Framingham, MA, USA.
L Adrienne CupplesThe Framingham Heart Study, Framingham, MA, USA.ORCID 0000-0003-0273-7965
Bingshan LiVanderbilt Genetics Institute, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0003-2129-168X
Thorsten M SchlaegerBoston Children's Hospital, Boston, MA, USA.
Alan R ShuldinerProgram in Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Baltimore, MD, USA.
Jeffrey R O'ConnellDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Ingo RuczinskiBloomberg School of Public Health, Biostatistics, Johns Hopkins University, Baltimore, MD, USA.
Braxton D MitchellDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-4920-4744
Nauder FaradayGeneSTAR Research Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Margaret A TaubBloomberg School of Public Health, Biostatistics, Johns Hopkins University, Baltimore, MD, USA.
Lewis C BeckerDivision of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Joshua P LewisDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA. jlewis2@som.umaryland.edu.ORCID 0000-0002-4107-6066
Rasika A MathiasGeneSTAR Research Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA. rmathias@jhmi.edu.ORCID 0000-0002-2282-9042
Andrew D JohnsonDivision of Intramural Research, Population Sciences Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA. johnsonad2@nhlbi.nih.gov.ORCID 0000-0001-6369-5178
University of Washington · USUniversity of Maryland, Baltimore · USJohns Hopkins University · USBrigham and Women's Hospital · USBaylor College of Medicine · USUniversity of Colorado Denver · USUniversity of Michigan · USNew York Genome Center · USBroad Institute · USNational Institutes of Health · USStanford University · USHarvard University Press · USUniversity of Mississippi · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · USEmory University · USIcahn School of Medicine at Mount Sinai · USVanderbilt University · USWashington University in St. Louis · USCleveland Clinic · US

Funding

ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI MARSH, LAURA · 1985 to 2007
$37.3M
Cardiovascular Genomics and Bioinformatics projectsZIAHL006170 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI JOHNSON, ANDREW · 2013 to 2025
$25.3M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) StudyU01HL105198 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2010 to 2014
$13.6M
Genotypic Determinants of Aspirin Response in High Risk FamiliesU01HL072518 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BECKER, LEWIS C · 2002 to 2008
$12.8M
Studies of Rare Genetic Variation in the Isolated Population of SardiniaR01HL117626 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABECASIS, GONCALO · 2013 to 2016
$10.5M
TRANSFUSION BIOLOGY AND MEDICINET32HL066987 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI JOHN P MANIS · 2001 to 2026
$10.2M
SNP HEALTH ASSOCIATION RESOURCE (SHARE)N02HL64278 · NHLBI · PI CHIN, SIANG · 2007 to 2007
$9.2M
Rare variants and NHLBI traits in deeply phenotyped cohortsR01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2014 to 2016
$8.9M
Pharmacogenomics of CVD risk ReductionU01GM074518 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2005 to 2009
$7.3M
Project-002U54DK110805 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ORKIN, STUART H, ZON, LEONARD IRA · 2016 to 2020
$5.9M
A Family-based Exome Sequencing Approach to Identify Platelet Aggregation GenesR01HL112064 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MATHIAS, RASIKA ANN · 2012 to 2015
$5.1M
Medical Research CouncilNCRR NIH HHS M01 RR000052NHGRI NIH HHS U01 HG009086NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS HHSN268201500014CNHLBI NIH HHS N01 HC025195NHLBI NIH HHS N02 HL64278NHLBI NIH HHS R01 HL087698NHLBI NIH HHS R01 HL112064NHLBI NIH HHS R01 HL117626NHLBI NIH HHS R01 HL118356NHLBI NIH HHS R01 HL120393NHLBI NIH HHS R01 HL121007NHLBI NIH HHS R01 HL137922NHLBI NIH HHS R01 HL141944NHLBI NIH HHS T32 HL066987NHLBI NIH HHS U01 HL072518NHLBI NIH HHS U01 HL105198NIA NIH HHS K01 AG059898NIDDK NIH HHS P30 DK072488NIDDK NIH HHS U54 DK110805NIGMS NIH HHS U01 GM074518
6 · The paper itself

Abstract

Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiology of myocardial infarction and stroke. To build upon prior GWAS, here we report on 16 loci identified through a whole genome sequencing (WGS) approach in 3,855 NHLBI Trans-Omics for Precision Medicine (TOPMed) participants deeply phenotyped for platelet aggregation. We identify the RGS18 locus, which encodes a myeloerythroid lineage-specific regulator of G-protein signaling that co-localizes with expression quantitative trait loci (eQTL) signatures for RGS18 expression in platelets. Gene-based approaches implicate the SVEP1 gene, a known contributor of coronary artery disease risk. Sentinel variants at RGS18 and PEAR1 are associated with thrombosis risk and increased gastrointestinal bleeding risk, respectively. Our WGS findings add to previously identified GWAS loci, provide insights regarding the mechanism(s) by which genetics may influence cardiovascular disease risk, and underscore the importance of rare variant and regulatory approaches to identifying loci contributing to complex phenotypes.

Indexed as

Chromosome MappingWhole Genome SequencingBase SequenceBlood PlateletsGenome-Wide Association StudyGTP-Binding ProteinsHEK293 CellsHumansK562 CellsPhenotypePlatelet AggregationPlatelet Function TestsPolymorphism, Single NucleotideQuantitative Trait LociReceptors, Cell SurfaceRGS ProteinsGTP-Binding ProteinsPEAR1 protein, humanReceptors, Cell SurfaceRGS18 protein, humanRGS Proteins

Identifiers

PMID34131117
PMCPMC8206369
OpenAlexW3170079927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.